These fellows will be working to turn ambitious ideas into actionable policy – from improving how frontier AI models are evaluated for government use to strengthening biosecurity protections and building the workforce needed to keep AI systems safe.
AI’s high-stakes outputs directly shape American economic, industrial, and technological outcomes. They must not be accepted entirely on the basis of institutional faith rather than verifiable evidence.
The clearinghouse will also neutrally mediate the assignment of auditors to audits—strengthening independence, trust, and ethical governance across the AI ecosystem.
Soft law was never meant to be a permanent solution. Treating it as one, and letting the sandcastle stand in for the skyscraper indefinitely, is how we end up with a decade of voluntary commitments and no enforceable accountability to show for it.
For our SOURCE CODE: AI Trust and Fairness Sprint, we’ve developed 10 memos with leading experts that are detailed, implementable policy solutions for burgeoning AI concerns.
Each publication developed under this initiative focuses on a distinct aspect of health and innovation, from artificial intelligence in healthcare, to rethinking national health frameworks, to advancing heat-health resilience.
The federal government is closely examining how it plays a role in supporting students, families, and educators – reimagining its approach to funding education R&D, pausing much of its investment in education outside the U.S., and completely reconceiving the structure of agencies responsible for education.
AI safety is a rapidly evolving field that draws attention from a diverse range of policymakers across the political spectrum, including those in Congress, federal agencies, and state and local governments.
We engage with the public, academia, and the private sector to foster a broader understanding of AI and emerging technology policy issues.
The U.S. bioeconomy is growing rapidly, innovation is needed to sustain and maintain this growth. Shaping policy to consider workforce development, advanced agriculture, bioindustrial and biotech sectors will be imperative to keep the needle moving forward.
We aim to catalyze a more nimble science funding ecosystem, capable of keeping up with and facilitating new innovations to improve the lives of people around the world.
